We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$25.5B
AUM Growth
+$2.25B
Cap. Flow
+$505M
Cap. Flow %
1.98%
Top 10 Hldgs %
11.65%
Holding
1,431
New
126
Increased
628
Reduced
408
Closed
91

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$85.5M
2
LOW icon
Lowe's Companies
LOW
+$66.8M
3
F icon
Ford
F
+$61.6M
4
XLNX
Xilinx Inc
XLNX
+$58.3M
5
TFC icon
Truist Financial
TFC
+$56M

Sector Composition

Rank Sector Weight
1 Technology 19.52%
2 Healthcare 16.23%
3 Financials 11.83%
4 Consumer Discretionary 10.58%
5 Industrials 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVTY icon
426
Revvity
RVTY
$15.6B
$10.7M 0.04%
+146,500
New +$10.5M
VRSN icon
427
VeriSign
VRSN
$26.9B
$10.7M 0.04%
93,482
-56,771
-38% -$6.34M
JNK icon
428
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.78B
$10.7M 0.04%
97,045
+4,890
+5% +$542K
ZNGA
429
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$10.6M 0.04%
2,653,800
+530,900
+25% +$2.07M
HYG icon
430
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.1B
$10.6M 0.04%
121,550
+6,400
+6% +$562K
BIG
431
DELISTED
Big Lots, Inc.
BIG
$10.6M 0.04%
188,400
+53,000
+39% +$2.87M
HSY icon
432
Hershey
HSY
$34.2B
$10.5M 0.04%
92,300
TFCFA
433
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$10.4M 0.04%
302,549
-72,063
-19% -$2.15M
UTHR icon
434
United Therapeutics
UTHR
$21.5B
$10.4M 0.04%
70,321
+3,692
+6% +$469K
NTCT icon
435
NETSCOUT
NTCT
$2.79B
$10.4M 0.04%
341,500
+60,200
+21% +$1.84M
NEWR
436
DELISTED
New Relic, Inc.
NEWR
$10.4M 0.04%
179,624
+8,624
+5% +$469K
MKC icon
437
McCormick & Company Non-Voting
MKC
$13.4B
$10.3M 0.04%
202,700
-86
-0% -$4.29K
PVH icon
438
PVH
PVH
$3.3B
$10.3M 0.04%
+75,200
New +$9.82M
AERI
439
DELISTED
Aerie Pharmaceuticals
AERI
$10.3M 0.04%
172,648
-33,069
-16% -$2.01M
RRC icon
440
Range Resources
RRC
$9.79B
$10.3M 0.04%
603,965
-100,052
-14% -$1.8M
GPN icon
441
Global Payments
GPN
$23.5B
$10.3M 0.04%
102,623
-8,338
-8% -$834K
MDRX
442
DELISTED
Veradigm Inc. Common Stock
MDRX
$10.3M 0.04%
706,300
+364,444
+107% +$5.06M
EWG icon
443
iShares MSCI Germany ETF
EWG
$1.68B
$10.3M 0.04%
310,810
-88,343
-22% -$2.91M
AAN.A
444
DELISTED
The Aaron's Company Inc Class A
AAN.A
$10.2M 0.04%
256,000
+74,200
+41% +$2.96M
SCCO icon
445
Southern Copper
SCCO
$160B
$10.2M 0.04%
234,309
-4,622
-2% -$184K
GGP
446
DELISTED
GGP Inc.
GGP
$10.1M 0.04%
432,834
+415,708
+2,427% +$9.25M
ZION icon
447
Zions Bancorporation
ZION
$9.92B
$10.1M 0.04%
199,051
+121,000
+155% +$5.79M
NBIS
448
Nebius Group N.V.
NBIS
$56.4B
$9.96M 0.04%
304,072
+67,127
+28% +$2.19M
IONS icon
449
Ionis Pharmaceuticals
IONS
$7.85B
$9.95M 0.04%
197,898
+95,294
+93% +$5.23M
AGIO icon
450
Agios Pharmaceuticals
AGIO
$1.96B
$9.9M 0.04%
173,137
+11,394
+7% +$717K

Similar funds

Axa's Q4 2017 Portfolio in Review

As of Q4 2017, Axa held 1,431 positions worth $25.5B, up 9.7% from $23.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Axa's Q4 2017 filing shows 126 new, 628 increased, 408 reduced and 91 closed positions. Its largest new stake was Pultegroup: 920,523 shares worth $30.6M. The largest sale was Gilead Sciences, an estimated $111M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q4 2017 buy was Pultegroup: 920,523 shares worth $30.6M.
  • Axa added most to Merck in Q4 2017, an estimated $85.5M increase.
  • Axa's biggest Q4 2017 reduction was Gilead Sciences, cutting an estimated $111M.
  • Axa fully exited Alaska Air in Q4 2017, selling an estimated $17.3M.
  • Axa's ten largest holdings make up 12% of its $25.5B portfolio in Q4 2017.
  • Axa opened 126 new positions and closed 91 in Q4 2017.
  • Axa's portfolio value rose 9.7% quarter-over-quarter to $25.5B.

Based on Axa's 13F filing for Q4 2017, filed 13 Feb 2018.